CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 73 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,501,425 | -30.3% | 7,570,695 | -19.9% | 0.01% | -28.6% |
| Q2 2023 | $127,049,355 | +1.6% | 9,453,077 | +25.3% | 0.01% | 0.0% |
| Q1 2023 | $125,058,264 | -57.3% | 7,542,718 | -52.1% | 0.01% | -22.2% |
| Q4 2022 | $292,887,280 | +202.1% | 15,746,628 | +108.4% | 0.01% | +50.0% |
| Q3 2022 | $96,936,000 | +154.3% | 7,555,423 | +39.0% | 0.01% | +200.0% |
| Q2 2022 | $38,117,000 | -0.4% | 5,437,479 | +17.7% | 0.00% | 0.0% |
| Q1 2022 | $38,283,000 | +12.0% | 4,617,955 | -8.6% | 0.00% | 0.0% |
| Q4 2021 | $34,195,000 | +6.3% | 5,050,989 | -16.8% | 0.00% | 0.0% |
| Q3 2021 | $32,168,000 | -6.7% | 6,069,381 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $34,491,000 | -16.3% | 5,998,448 | -32.9% | 0.00% | 0.0% |
| Q1 2021 | $41,186,000 | +101.7% | 8,933,983 | +46.1% | 0.00% | +100.0% |
| Q4 2020 | $20,421,000 | -9.9% | 6,113,930 | -19.9% | 0.00% | -50.0% |
| Q3 2020 | $22,668,000 | -26.5% | 7,632,352 | +14.3% | 0.00% | 0.0% |
| Q2 2020 | $30,846,000 | +7.7% | 6,676,601 | -10.3% | 0.00% | -33.3% |
| Q1 2020 | $28,647,000 | +3.0% | 7,440,822 | +0.3% | 0.00% | +50.0% |
| Q4 2019 | $27,819,000 | +44.5% | 7,418,295 | +104.6% | 0.00% | +100.0% |
| Q3 2019 | $19,257,000 | +175.4% | 3,626,626 | +99.1% | 0.00% | 0.0% |
| Q2 2019 | $6,993,000 | -15.7% | 1,821,191 | +11.9% | 0.00% | 0.0% |
| Q1 2019 | $8,298,000 | +177.8% | 1,627,095 | +4.6% | 0.00% | – |
| Q4 2018 | $2,987,000 | -48.3% | 1,555,977 | +1.9% | 0.00% | – |
| Q3 2018 | $5,773,000 | +28.6% | 1,527,450 | +6.2% | 0.00% | – |
| Q2 2018 | $4,489,000 | +56.1% | 1,438,928 | +19.5% | 0.00% | – |
| Q1 2018 | $2,876,000 | -35.4% | 1,203,640 | +5.8% | 0.00% | – |
| Q4 2017 | $4,451,000 | +86.9% | 1,137,798 | +20.5% | 0.00% | – |
| Q3 2017 | $2,382,000 | -8.0% | 944,295 | +0.7% | 0.00% | – |
| Q2 2017 | $2,590,000 | +2843.2% | 938,195 | +1971.1% | 0.00% | – |
| Q1 2017 | $88,000 | +87.2% | 45,300 | 0.0% | 0.00% | – |
| Q4 2016 | $47,000 | -4.1% | 45,300 | 0.0% | 0.00% | – |
| Q3 2016 | $49,000 | +48.5% | 45,300 | 0.0% | 0.00% | – |
| Q2 2016 | $33,000 | -97.6% | 45,300 | -96.2% | 0.00% | – |
| Q1 2016 | $1,395,000 | -49.8% | 1,193,974 | +5.4% | 0.00% | – |
| Q4 2015 | $2,777,000 | -10.3% | 1,132,629 | +9.9% | 0.00% | – |
| Q3 2015 | $3,095,000 | +13.3% | 1,030,431 | +55.8% | 0.00% | – |
| Q2 2015 | $2,731,000 | +1315.0% | 661,259 | +1389.3% | 0.00% | – |
| Q1 2015 | $193,000 | +45.1% | 44,400 | 0.0% | 0.00% | – |
| Q4 2014 | $133,000 | -18.9% | 44,400 | -10.1% | 0.00% | – |
| Q3 2014 | $164,000 | +36.7% | 49,400 | +4.7% | 0.00% | – |
| Q2 2014 | $120,000 | +12.1% | 47,200 | 0.0% | 0.00% | – |
| Q1 2014 | $107,000 | +16.3% | 47,200 | 0.0% | 0.00% | – |
| Q4 2013 | $92,000 | – | 47,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |